Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Lithium has been the most effective psychopharmacological drug in the long-term treatment of patients with recurrent unipolar and bipolar affective illness. As a result of its widespread and longtime use in patients with recurrent affective disorders, psychiatrists have become increasingly aware of the whole spectrum of lithium's potential side effects. One of the side effects associated with its chronic use is lithium-induced nephropathy. In a recent cross-sectional study published in BMC Medicine, Alberto Bocchetta et al. add further information to this topic, demonstrating that duration of lithium treatment is associated with impaired glomerular function in patients with recurrent or chronic affective disorders. The present paper will discuss the implications of this and other related recent research on our management of patients with recurrent affective disorders. In this context the importance of shared decision making and close monitoring of kidney function is highlighted, including the regular assessment of the glomerular filtration rate, to provide best possible care to our patients maintained on lithium treatment.See related research article here http://www.biomedcentral.com/1741-7015/11/33.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., de Jong, P. E., Coresh, J., El Nahas, M., Astor, B. C., Matsushita, K., Gansevoort, R. T., Kasiske, B. L., & Eckardt, K.-U. (2011) · Kidney International · doi:10.1038/ki.2010.483 · Cited by 2,345
Lithium-induced nephropathy: Rate of progression and prognostic factors
Presne, C., Fakhouri, F., Noël, L.-H., Stengel, B., Even, C., Kreis, H., Mignon, F., & Grünfeld, J.-P. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00096.x · Cited by 231 · cited 1×
“Importantly, stopping lithium may only have beneficial effects for the kidney as long as the creatinine clearance is > 40 mL/ minute, otherwise the underlying pathology may progress despite the elimination of the triggering toxic compound (lithium), with parallel deterioration of kidney function at the same rate as be…”
Background
Cited by
Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
Self-citationTondo, L., Abramowicz, M., Alda, M., Bauer, M., Bocchetta, A., Bolzani, L., Calkin, C. V., Chillotti, C., Hidalgo-Mazzei, D., Manchia, M., et al. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0096-2 · Cited by 125
Self-citationPharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa033 · Cited by 76
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study
Bocchetta, A., Ardau, R., Fanni, T., Sardu, C., Piras, D., Pani, A., & Del Zompo, M. (2015) · BMC Medicine · doi:10.1186/s12916-014-0249-4 · Cited by 77
“discussed the implications of the risk of lithium-induced nephropathy in long-term treatment [5].”
BackgroundTreatment of lithium intoxication: facing the need for evidence
Haussmann, R., Bauer, M., von Bonin, S., Grof, P., & Lewitzka, U. (2015) · International Journal of Bipolar Disorders · doi:10.1186/s40345-015-0040-2 · Cited by 75
Self-citation
Metadata
- Authors
- Severus, E., & Bauer, M.
- Venue
- BMC Medicine
- Published
- 2013-02-11
- Volume
- 11
- Issue
- 1
- Pages
- 34-34
- ISSN
- 1741-7015 (ISSN-L)
- OpenAlex
- W2071430319
- Cited by
- 22
- References
- 2
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders. https://app.cochat.ai/papers/10.1186/1741-7015-11-34
- The paper
- Severus, E., & Bauer, M. (2013). Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders. BMC Medicine. https://doi.org/10.1186/1741-7015-11-34
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.